The two outermost compartments of skin are populated by different Ag-presenting dendritic cell types. Epidermal Langerhans cells (LCs) are evolutionarily adapted to the continuous presence of harmless skin commensals by the selective lack of cell surface TLRs that sense bacteria.
In this article, we analyze the ability of LCs and dermal dendritic cells (DDCs) to respond to virus infection. Live virus and intracellular TLR3-agonist dsRNA commit LCs more effectively than DDCs to stimulate naive CD8 + T cell expansion and their differentiation into effector cells. This potent CD8 + T cell-promoting capacity of LCs is causally related to high levels of virus-induced CD70 expression but not to IL-12 production. These data suggest a remarkable specialization of LCs in the induction of pathogen class-specific adaptive immunity. Whereas LCs ignore bacteria, they are superior to DDCs to initiate effective CD70-mediated CD8 + T cells in response to virus stimulation. The Journal of Immunology, 2011, 187: 000-000. P rotective immunity against different classes of pathogens requires different classes of T cell-mediated immune responses. The development of an appropriate type of effector T cells during infection is initiated by pathogen-induced commitment of dendritic cells (DCs), resulting in the presentation of pathogen-derived peptides to naive T cells in the context of signal 3 molecules that polarize the activated T cells into specialized effector T cells (1, 2) . A well recognized concept is that DCs obtain T cell-polarizing properties by sensing different classes of pathogens via different groups of cell surface-, cytoplasmatic-, or endosomal pattern-recognition receptors (PRRs) (3, 4) . Accordingly, viruses are recognized by cytoplasmic and endosomal PRRs, which programs DCs for development of cytotoxic effector CD8 + T cells. Protective CD8 + T cell-mediated immunity largely depends on the ability of CD8 + T cells to expand and acquire effector molecules, including the cytotoxic molecules granzyme B (GrB) and perforin as well as antiviral cytokines such as IFN-g and TNF-a (5, 6). DC-derived mediators that drive the development of effector CD8 + T cells include IL-12 (1, 7) and the costimulatory cell surface molecule CD70, a TNF superfamily member that ligates CD27 (8) (9) (10) .
DCs form a heterogeneous population with regard to differences in lineage and localization in tissue compartments. DC subtypes can display intrinsic differences in pathogen recognition and T cell-polarizing capacity. We and others have recently shown that, in contrast to dermal DCs (DDCs), TGFb-driven development of human epidermal Langerhans cells (LCs) is associated with a lack of expression of cell surface TLRs 2, 4, and 5, resulting in their selective inability to respond to bacteria (11, 12) . This unresponsiveness probably prevents T cell-mediated pathology upon superficial injury and subsequent entry in the epidermal compartment of relatively harmless commensal bacteria that permanently adhere to healthy skin (13) . However, viruses entering the epidermis are always a potential danger. Therefore, an important question is whether LCs do effectively initiate CD8 + T cell immunity. Indeed, both LCs and DDCs express PRRs that recognize important viral RNA or DNA patterns (e.g., similar levels of endosomal TLR3 (12)). Interestingly, human LCs more effectively prime allogenic CD8 + T cells in homeostatic conditions (14) . In this study, we analyzed the relative role of LCs in the initiation of virus-driven CD8 + T cell responses.
Materials and Methods

Priming LCs and DDCs
Human LCs and DDCs from random healthy donors generated as previously described (12) were stimulated for 48 h with p(I:C) (20 mg/ml; SigmaAldrich), influenza virus (FLU) A/PR/8/34 (a gift from G. Rimmelzwaan, Erasmus Medical Center, Rotterdam, The Netherlands), or R848 (InvivoGen) and analyzed by FACS, using anti-CD83-APC, anti-CD86-PE, anti-CD80-FITC, and anti-HLA-DR-PerCP (BD Biosciences), anti-HLA-ABC-FITC (Serotec), anti-ICAM-1 (Immunotech), anti-CD70 (BD Biosciences), and PE-conjugated goat anti-mouse (Jackson ImmunoResearch Laboratories). IL-12p70 levels in 24-h supernatants were determined by ELISA as described previously (15 
CD8
+ T cells were purified by sort using CD27-PE, CD45RA-FITC, CD45RO-allophycocyanin, and CD8-allophycocyanin-cy7 (BD Biosciences).
T cell assays
Primed LCs and DDCs from the same donor were counted and cocultured in a flat-bottom 96-wells plate with allogeneic naive CD8 + T cells (1:4) with Staphylococcus aureus enterotoxin B (0.1 pg/ml; Sigma-Aldrich) in the absence or presence of neutralizing mAb (10 mg/ml) against human CD70 (16) T ratios at 37˚C in the presence of S. aureus enterotoxin B (5 ng/ ml). Chromium release was measured after 4 h, and specific lysis was calculated as (experimental release 2 spontaneous release/total release 2 spontaneous release) 3 100.
Statistics
Significance was analyzed with GraphPad (GraphPad InStat) using paired Student t test for data of LCs and DDCs from the same donor. A p value ,0.05 was considered significant.
Results and Discussion
To assess to what extent LCs and DDCs initiate antiviral T cell responses, the two DC subsets were stimulated with polyinosinic:polycytidylic acid [p(I:C)], a TLR3-agonist dsRNA to mimic viral priming, or exposed to live FLU and analyzed for their ability to activate allogeneic naive CD8 + T cells. FLU was chosen as a model virus because it is recognized by various intracellular PRRs that are expressed by both LCs and DDCs and does not exploit immune evasion strategies that substantially interfere with the induction of T cell responses. LCs were much better stimulators of naive CD8 + T cell proliferation than DDCs after priming with p(I:C) or FLU (Fig. 1A, 1B) , which was not associated with different sensitivity of apoptosis of these DC types (data not shown). No or only low T cell proliferation was induced by immature LCs or LCs primed by bacteria-associated TLR ligands (data not shown). This is in line with the finding that LCs do not respond to bacterial ligands (12) . Next, we investigated the capacity of LCs to induce functional differentiation of naive CD8 + T cells by analyzing the expression of molecules characteristic for effector functions. The numbers of CD8 + T cells expressing the antiviral cytokines IFN-g and TNF-a were significantly higher within the T cell population induced by LCs than by DDCs (Fig. 1C) . Interestingly, LCs also more effectively induced IL-2-producing CD8 + T cells than DDCs (Fig. 1C) . Because IL-2 is important for T cell proliferation, the high IL-2 production may contribute to the strong CD8 + T cell proliferation induced by LCs. Importantly, LCs were also more potent than DDCs in inducing the production of the cytotoxic effector molecule GrB. LCs not only promoted GrB expression in naive CD8 + T cells more rapidly than DDCs, but also induced higher levels of GrB in markedly more CD8 + T cells ( Fig. 2A) . In line with the higher expression of effector molecules, the CD8 + T cells activated by LCs were significantly more potent in killing target cells (Fig. 2B ) than p(I:C)-and FLU-primed DDCs at all E:T cell ratios tested (Fig. 2C) . These data collectively show that p(I:C)-and FLU-primed LCs are highly efficient in the induction of cytotoxic effector CD8 + T cells that have a greater cytolytic activity on a per cell basis.
We subsequently investigated the mechansisms underlying the superior induction of CD8 + effector T cells by LCs. As shown in Fig. 3A , we found that LCs and DDCs express similar levels of the costimulatory molecules CD86, CD80 and CD83, as well as Ag-presenting MHC class I and MHC class II molecules, upon priming by p(I:C) or FLU. These cells also express similar levels of ICAM-1, which is known to promote CD8 + T cell activation (17) . Furthermore, LCs and DDCs produced comparable amounts of IL-12 upon priming with p(I:C) and FLU (Fig. 3B) , which is in line with our previous findings (12) . Surprisingly, a major difference between LCs and DDCs is that CD70 was consistently upregulated only in LCs after stimulation with p(I:C) or FLU (Fig.  3C) , which was not dose dependent (i.e., not related to a difference in poly(I:C) sensitivity between the DC subsets. In a minority of the DC donors, CD70 is also upregulated in LCs upon priming with R848, a synthetic ligand of the intracellular TLR7 and TLR8 which both recognize single stranded RNA (Supplemental Fig. 1 ). As reported before (12) , LCs selective lack cell surface PRRs and did not respond at all to whole bacteria or to classical agonists of cell surface sensors of bacteria. Notably, CD70 was not upregulated upon stimulation of DDCs by any other cell surface or intracellular TLR ligands tested, including ligands of TLR2, 3, 4, and 7/8 (data not shown). Moreover, LCs and DDCs did not upregulate other TNF superfamily members CD134L (OX40L) or CD137L (4-1BB) in any tested condition (data not shown).
To assess the contribution of virus-induced CD70 to the capacity of LCs to generate effector T cell responses, we cocultured p(I:C)-or FLU-primed LCs with naive CD8 + T cells in the presence of neutralizing mAb against CD70. As shown in Fig. 4 , neutralizing CD70 substantially and consistently reduced the proliferation, IFN-g production and GrB expression of naive T cells induced by p(I:C)-or FLUprimed LCs (Fig. 4A) down to the same levels as observed with DDCs (Fig. 4A) . As expected, the presence of blocking Abs against CD70 did not affect the CD8 + T cells induced by p(I:C)-or FLU-primed DDCs (Fig.4A) . Surprisingly, despite previous data describing a role of IL-12 in the induction of CD8 + T cell mediated responses, we did not find an effect of blocking IL-12 on the induction of CD8 + T cell proliferation, whereas GrB and cytokine production was not substantially different for both DC subsets (Fig. 4B) . These data indicate that the virus-induced selective upregulation of CD70 by LCs is the critical feature that enhances their capacity to induce effector CD8 + T cell responses compared with virus-primed DDCs that lack CD70.
The importance of CD70 is in line with previous studies, in human as well as mouse models, which show a critical role for DC-associated expression of CD70 in CD8 + T cell responses . 9) . Whereas mouse bone marrow-derived DCs, DC cell lines or ex vivo DCs readily express CD70 after in vitro stimulation with TLR ligands, in particular with the combination of TLR and CD40 agonists (16, 18, 19) , human monocyte-derived DCs, which are similarly prepared as our DDCs, or ex vivo conventional DCs, do not express CD70 after stimulation through TLR3, TLR4 or CD40 (20, 21) . Variable amounts of CD70 are, however, expressed by these DCs upon stimulation by combinations of TLR and CD40 agonists (20, 21) or upon supplementation of PGE 2 (21) . The full physiological meaning of these findings remains to be established to date. Although these in vitro data suggest that CD70 expression is a general feature of DCs, in vivo mouse model studies show that CD70 expression is restricted to particular DC subsets. For example, s.c. or i.p. injected TLRs and CD40 agonists induce in spleen selective CD70 expression on CD8a + DCs (22) or on CD8a + CD11b + DCs (18) . In addition, a recent study indicates that FLU infection in the lung is controlled by CD70 expressed selectively found in the draining lymph nodes on immigrated tissue CD103 2 CD11b + DCs (23). To our knowledge, the present findings are the first on the ability of a human DC subset to acquire high levels of CD70 in response to mere TLR3 ligation. The results indicate that, like for mouse DC subsets, human CD70 expression is differentially regulated in closely related DC subsets. The differential ability to express CD70 by LCs and DDCs upon TLR3, and to some extent TLR7/8, ligation is surprising because both DC subsets express comparable amounts of these intracellular receptors (12) . The in vivo and in vitro development of the particular phenotype of LCs, such as their expression of molecules that let these cells home into the epidermis and their ability to selectively ignore bacteria, is critically driven by TGF-b. At present, it is unclear how TGF-b primes LCs for the unique ability to express these high levels of CD70.
Because of its effects on cell mediated immune responses, p(I:C) is often considered as an adjuvant in antiviral vaccines. The unique induction of high levels of CD70 on certain DC subsets further stress the potential of p(I:C) in promoting CD8 + T cell responses upon vaccination against intracellular pathogens. This may also apply for cancer therapy, since stimulation of CD27 results in complete protection against a model tumor and expression of CD70 on steady-state DCs in mice elicited tumor-eradicating CD8 + T cell responses (8, 24) .
Collectively, this study suggests an important role for LCs as first line of defense against viruses in the skin. A series of viral infection studies have advocated the general concept that CD8 + T cells are not directly activated by migrating DC subsets, including LCs, but rather by resident DCs that have picked up viral Ag in draining lymphoid tissue (25) (26) (27) . However, this concept has been challenged by more recent studies in mouse models of FLU (23, 28) and Leishmania (29, 30) , which provide evidence that migratory DCs, including LCs, are able to directly present Ags to CD8 + T cells. In conclusion, our data provide further insight in the relative roles of epidermal and dermal DCs in the initiation of T cell immunity. Whereas LCs ignore bacteria and immunity is only initiated via DDCs when these microbes have crossed the epidermis where they are potentially pathogenic, LCs have the potential to readily initiate effective antiviral immunity to challenge viruses that upon skin contact readily infect the epidermal layer. Knowledge about the capacity of different DC subsets to induce T cell responses is not only essential in understanding their roles in immunity but could also be beneficial for the development of effective immunotherapies.
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